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Abstract
The aim of this review is to provide mainly an outlook of the synthesis and 
characterization of chiral mono- and α-diimines ligands and their Pd(II) complexes 
carried out in our group in the last few years. Some other issues with simple chiral 
imines synthesized in our lab are also outlined. The report includes details about 
their versatile coordination patterns, biological activity in cancer cell lines, and 
engaging properties in different fields, such as materials science.
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1. Introduction
The importance of Schiff bases resides in their structural variety as well as their 
ability to form a wide range of appealing structural arrangements depending of the 
constituents parent molecules with transition metals by acting as N-donor ligands, 
affording mono-, bi- and polynuclear complexes [1–3]. Accordingly, Schiff bases 
display a broad range of useful biological activities such as, inter alia, antibacterial, 
antifungal, antidiabetic, anti-inflammatory, and anticancer agents generating a 
huge interest in the medicine field [4–8]. The proper choice of the ligands in metal 
complex synthesis is essential for the activity that they could present since they 
determine some aspects like reactivity and lipophilicity.
We have focused our attention on the synthesis of chiral compounds since 
chirality is almost omnipresent in a broad range of organic molecules in the human 
body such as proteins, enzymes, amino acids, carbohydrates, and nucleosides. The 
body acts like a chiral selector metabolizing enantiomers by separate pathways 
and generating different pharmacological activities. For that reason, the current 
approach is to target specific molecules by designing more selective drugs, espe-
cially in chemotherapy where the distinction between cancerous and normal cells is 
essential for the success of the treatment and the reduction of the toxicity.
Likewise, the search of more eco-friendly procedures in the synthesis of organic 
molecules is one of the goals of our research group. Green Chemistry techniques 
like the use of microwave irradiation and solvent-free reactions display numerous 
advantages such as shorter reaction times, minimum waste, operational simplicity 
as well as reduction of thermal degradative byproducts along with cleaner work-up 
and generally higher yields [9, 10].
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On the other hand, the discovery of anticancer activity of the cisplatin was a 
key event for the introduction of metal-based compounds to medicine, and the 
interest on these kind of compounds increased significantly in the last decades due 
to their ability to coordinate ligands in a three-dimensional configuration and bind 
to specific cell targets. Platinum-based drugs, particularly cisplatin, are widely use 
in the treatment of different types of cancer, but the toxicity and high resistance 
that they present limits their use. Therefore, the major challenge for chemists is the 
design of new drugs with less side effects. Efforts have been made to consider other 
metal-based complexes with cytotoxic properties, such as palladium complexes. 
They are known to show structural and thermodynamic analogy in regard to Pt(II) 
complexes, and display versatile coordination behavior and interesting properties. 
Palladium complexes of various donor-atom ligands have been found to possess 
engaging anti-tumor activity, as well as anti-inflammatory, anti-microbial, antiviral 
and antifungal properties [11, 12].
2. Chiral Pd(II) complexes
The incorporation of optically pure aromatic amines into α-dicarbonylic com-
pounds bearing aromatic rings such as benzil in a 1/1 ratio generating enantiopure 
α-ketoimines was the first step for our investigations, considering that a flexible 
X〓C▬C〓N (X = O, N) skeleton could lead to diverse coordination modes [13]. 
Then, the chiral mono-imine derived from (S)-(−)-1-phenylethylamine and benzyl 
under microwave radiation in solvent-free conditions led to the formation of the 
N-donor ligand (S)-(−)-(1-phenylethylimino)benzylphenylketone 1 which was 
allowed to react with K2PdCl4 giving two Pd complexes: a mono- 2 and a dinuclear 
Pd(II) 3 complexes (Figure 1).
On the other hand, in vitro assays are essential to determine the capacity of the 
compounds to modify basic cellular functions on different cancer cells. We have 
Figure 1. 
Mono- and dinuclear chiral Pd(II) complexes 2 and 3 with their respective IC50 values.
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employed sulforhodamine B staining to determine the cytotoxicity of our com-
plexes, given the ease and high reproducibility of this method. By keeping constant 
the panel of human cancer cell lines (U251: central nervous system, PC-3: prostate 
cancer, K562: leukemia, HCT: colon cancer and MCF-7: breast cancer) we are able to 
compare the effects of the compounds in each cell and determine how the variations 
on the structure affect the activity. Those cell lines represent the most common 
types of cancer [14].
Complex 2 presented a common square planar geometry at the metal center with 
two Cl atoms trans and two ligands bonded through the N atoms N8 and N58 in a 
trans configuration while complex 3 is a dinuclear Pd(II) complex with one mol-
ecule in the asymmetric unit. For the binuclear complex, the coordination is carried 
through the N atoms (N8 and N58), like complex 2, and the C atoms of the phenyl 
rings of the imino functions (C14 and C64). The low level of electronic delocaliza-
tion in the ligand induced a high level of flexibility in the formation of complex 3, 
producing a major distortion, due to the bite angles Cl-Pd-Cl and N-Pd-Cl.
The complexes 2 and 3 were tested by sulforhodamine B assays against U251, 
PC-3, K562, HCT and MCF-7 human cancer cell lines. Both compounds displayed 
cytotoxic activity, especially toward K562 (IC50: 26.5 ± 0.4 and 14.8 ± 1.1 μM for 
complex 2 and 3, respectively) and MCF-7 (IC50: 34.5 ± 2.5and 13.1 ± 1.0 μM for 
complex 2 and 3, respectively). In general, the binuclear complex was slightly better 
for all cell lines exhibiting lower IC50 values, while complex 2 surpassed the dose of 
100 μM in U251 and HCT-15 cell lines [14].
Also, we have reported the synthesis of cyclopalladated compounds. 
Considering that our previous compounds displayed attractive properties, we 
decided to vary the substituents, replacing the aromatic rings in the α-dicarbonylic 
compounds by aliphatic substituents, such as two methyl groups and attaching also 
two chiral entities, i.e., to prepare α-diimines, as such kind of compounds have also 
a flexible N〓C▬C〓N skeleton, displaying outstanding electron donor and accep-
tor properties and can potentially act in a variety of coordination modes. Then, 
the chiral diimines 4–5 were synthesized under solvent-free conditions starting 
from (S)-(−)-1-phenylethylamine and (S)-(−)-1-(4-methylphenyl) ethylamine 
with 2,3-butanedione, respectively. The reaction between Na2PdCl4 and each of 
the ligands 4–5 in a MeOH solution at ambient temperature led to the formation of 
the complexes 6 and 7 (Figure 2) [15]. In this case, the complex 6 is mononuclear 
Figure 2. 
Synthesis of chiral Pd complexes 6–7.
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with the Pd(II) center adopting a distorted square planar Pd[N2CCl] coordination 
geometry where one benzene group is bonded to the metal center while the other is 
free of coordination. The steric hindrance produced by the benzene group and the 
formation of a Pd-C bound apparently blocked the dimerization of the complex. 
The solid obtained from complex 7 was not able to crystallize.
Both complexes 6 and 7 exhibited cytotoxic activity toward the panel of cul-
tured cell lines previously mentioned, mainly against U251 and K562 cancer cells 
with IC50 values of 19.8 and 22.5 μM for complex 7, and 23.6 and 25.44 μM for 6, 
respectively. According to the data, 6 cannot be considered a good candidate as an 
anticancer agent since its IC50 values are too high for PC-3 and HCT-15, exceeding 
the dose of 100 μM. These compounds offer a better activity against U251 cell line 
compounds than the α-ketoimine complexes previously mentioned.
Thereafter, we carried out the synthesis of new unsymmetrical α-diimines by 
replacing one methyl group with a hydrogen atom and enlarging the number of chi-
ral amines. A different method was used with the aim to improve the yields. Then, 
methylglyoxal and optically active aromatic and alicyclic primary amines were 
stirred in diethyl ether with Na2SO4 for 24 hours at room temperature leading to the 
formation of the ligands 8–11 (Figure 3). Solutions of the ligands 8–11 in benzene 
were treated this time with dichloro(1,5-cyclooctadiene) palladium (II) and stirred 
at room temperature under argon atmosphere to form complexes 12–15 (Figure 4). 
Worth-mentioning is that the coordination of the ligands took place in two different 
modes: chelating (σ, σ, N, N′) and monodentate (σ-N) [16].
Complexes 12 and 13 expose a s-cis chelate system and although they are 
chemically similar they crystallize in different way, in two distinct space groups. 
We believe that the crystal symmetry modification is a consequence of the crystal-
lization rather than small conformational variations. The complex 15 displays two 
diimine ligands which are coordinated to the metal center in a trans square planar 
geometry, and the same behavior is observed in complex 14. The importance of 
the trans-geometry around the Pd center has been attributed to the comparatively 
higher cytotoxicity values as those for cis-isomers.
It seems that the small substituents on the imine N atoms facilitates the ori-
entation toward σ, σ, N, N′ coordination mode, stabilizing the complex through 
the chelate effect, while the monodentate (σ-N) coordination mode is favored by 
sterically hindered systems.
The results of the cytotoxic assay showed that Pd complexes with monodentate 
(σ-N) coordination mode (14 and 15) displayed IC50 values >100 μM; these com-
plexes were dismissed for further assays because the doses required to inhibit cell 
Figure 3. 
Synthesis of chiral α-diimine ligands 8–11.
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growth were too high. Complexes 12 and 13 also possessed cytotoxic activity against 
U251, PC-3, K562, HCT and MCF-7 cell lines, where IC50 ranged from 66 to 91 μM.
As such results were unpromising, we reconsidered the α-dicarbonylic com-
pounds bearing aromatic rings, but this time with heterocyclic entities. By using 
the method previously used (microwave irradiation in solvent-free conditions), the 
chiral α-ketoimines 16–17 were synthesized from (S)-(−)-1-phenylethylamine and 
(S)-(−)-1-(4-methylphenyl) ethylamine with 2,2′-pyridil, respectively (Figure 5).
Complexes 18–19 (Figure 6) were synthesized by the reaction between 
Pd(COD)Cl2 and each ligand 16-17 in a solution of benzene. It was not possible to 
obtain a monocrystal of complex 19, however the crystal data of 18 showed that 
α-ketoimine 16 is a bidentate ligand and Pd(II) displayed a square-planar coordina-
tion geometry. In the case of 16, the conjugation of imine and carbonyl double 
bonds with the aromatic systems and the substitution of vicinal C1 and C2 by 
pyridil rings implied that the ligand adopted a gauche conformation [17].
The data from the sulforhodamine B assay evidenced that none of the com-
pounds possess cytotoxicity toward K562, however they are able to inhibit cell 
Figure 4. 
Synthesis of chiral Pd(II) complexes 12–15.
Figure 5. 
Synthesis of chiral imines 16–17.
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growth in U251, PC-3, HCT-15 and MCF-7, being 18 slightly better than 19 for all 
cell lines. The studies suggest that the nature of the aromatic rings have an impact in 
the cytotoxicity and the coordination mode.
Such results were not particularly impressive (at least a factor of 10 poorer than 
cisplatin), but they certainly do show variations in activity as well in the other cases.
It must be pointed out that even when the Pd-Schiff Base-complexes displayed 
cell growth inhibition against different classes of cancer, the IC50 that they have 
showed are not comparable with cisplatin. In general, Pd(II) complexes are kineti-
cally less stable than those of Pt(II), by losing their structural integrity in biological 
fluids in a short period of time due to their rapid exchange. More specific studies 
in vitro and in vivo need to be done to determine their toxicity and to understand 
in a better way the mechanisms of action since it will aid the development of more 
efficient palladium-based drugs.
On the other hand, considering other alternatives to the flexible X〓C▬C〓N 
(X = O, N) skeleton, for example as a heterodiene, we have also reported the 
microwave-assisted Diels-Alder [4+2] cycloaddition reaction of the optically 
pure α-ketoimines 20–21 and α-diimines 22–23, with fullerene C60. The chiral 
α-ketoimines 20–21 were readily synthesized in quantitative yield under solvent-
free conditions starting from (S)-(−)-1-phenylethylamine and (S)-(−)-1-(4-
methylphenyl) ethylamine with pyruvaldehyde, respectively, and upon reaction of 
C60 under focused-microwave irradiation in benzene, after 20 min the formation of 
the adducts 24–25 was observed (Figure 7) [18].
With the chiral α-diimines 22–23, which were also readily prepared from (S)-
(−)-1-phenylethylamine and (S)-(−)-1-(4-methylphenyl) ethylamine with pyruv-
aldehyde, respectively, the adducts 26–27 were obtained (Figure 8).
In addition, extending our studies to include some other transition metals, we 
have reported the preparation of chiral Hg(II) complexes with simpler chiral imines 
28–30 as they present some relevant crystallographic features along with antimicro-
bial activity. [19] Thus, the solvent-free reaction of 2-pyridylcarboxaldehyde with 
optically active aromatic and alicyclic primary amines afforded the chiral imines 
28–30 in almost quantitative yields (see Figure 9).
Solutions of the chiral imines 28–30 in methanol were treated with HgCl2 with 
stirring at room temperature for 1 h, leading to the formation of complexes 31–33 
(Figure 10).
Figure 6. 
Chiral Pd(II) complexes 18–19.
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Likewise, preliminary data have revealed that chiral imines 34–37 derived from 
2-piridylcarboxaldehyde and the optically active aromatic amines (S)-(−)-1-(4-
methylphenyl) ethylamine, (S)-(−)-1-(4-metoxyphenyl) ethylamine, (S)-(−)-1-
(4-chlorophenyl) ethylamine and (R)-(+)-1-(4-fluorophenyl) ethylamine under 
solvent-free conditions (Figure 11) were allowed to react with Zn(CLO)4 affording 
Figure 7. 
Adducts 24–25 synthesized.
Figure 8. 
Adducts 26–27 synthesized.
Figure 9. 
Synthesis of chiral imines 28–30.
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Zn complexes 38–41 (Figure 12) with cytotoxic activity against the aforemen-
tioned human cancer cell lines as well as low toxicity in brine shrimps, along with 
antibacterial activity against P. aeruginosa, E. coli and S. aureus. Such results will be 
reported in due time.
On the other hand, simpler chiral imines have triggered interest in some other 
fields, especially in materials science; where by changing the substituents in the 
chiral moiety can afford morphological, optical and structural changes resulting in 
photoluminescent properties, which are extremely interesting since the viewpoint 
of physicists. In this context, we have recently reported a series of halogenated 
Figure 11. 
Chiral imines 34–37.
Figure 10. 
Chiral Hg(II) complexes 31–33.
9Chiral Mono- and α-Diimines and Their Pd(II) Complexes with Anticancer Activity
DOI: http://dx.doi.org/10.5772/intechopen.80796
imines (Figure 13) derived from 2-naphtaldehyde and optically pure halogenated 
amines, under solvent-free conditions. As a result, imines 42–44 with a lamellar 
morphology exhibited photoluminescent properties. By changing the halogen 
atoms in the chiral moiety of the imines, the crystalline packing was modified. The 
bands observed in the visible region are caused by interstitial defects, vacancies, 
Figure 12. 
Chiral Zn(II) complexes 38–41.
Figure 13. 
Chiral halogenated imines 42–44.
Figure 14. 
Chiral imines 45–48.
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grain boundaries and stacking faults in the crystals The intensity of the bands 
increased in the following order: ▬F < ▬Cl < ▬Br, according to the increase in 
atomic radii. These features result attractive because of their possible applications in 
organic electroluminescent devices, organic light- emitting diodes, etc. [20, 21].
Likewise, in a series of chiral imines derived from 2-naphtaldehyde but with the 
halogen atoms in the para-position of the benzene ring of the amines replaced by 
other functional groups, such as ▬CH3, ▬OCH3 and naphthyl groups, imines 45–48 
(Figure 14) exhibited green luminescence. As the previous results, the variations on 
the functional group as well as the molecular packing determined the morphological 
changes and consequently the luminescent properties of the imines [22].
3. Conclusion
The chemistry of Schiff bases and their transition metal complexes, especially Pd, 
is a field that is being noticed not only for their remarkable biological properties but 
also for their extensive applications in other fields. This area requires further studies 
to be carried out, and improvements in the permeability and transport are some of 
the factors to take into account in the design of these metal-based complexes.
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